20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Advancing Cardiorenal Health: The Role of Finerenone

NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying advanced pharmaceutical ingredients. Today, we explore Finerenone (CAS 1050477-31-0), a pivotal compound in the ongoing effort to combat cardiorenal diseases.

Finerenone is distinguished as a selective, non-steroidal mineralocorticoid receptor (MR) antagonist. Its innovative design allows for targeted action on the MR, a key factor in the progression of inflammatory and fibrotic processes in the heart and kidneys. This selectivity is a significant improvement over older steroidal MRAs, leading to a better safety and tolerability profile.

The finerenone mechanism of action is crucial for its therapeutic efficacy. By inhibiting the MR, Finerenone counteracts the detrimental effects of aldosterone, helping to preserve organ function in patients suffering from conditions like diabetic kidney disease and heart failure. The ability to buy Finerenone from reputable sources ensures the integrity of its pharmacological effects.

Research into finerenone for diabetic kidney disease has been particularly groundbreaking. Clinical studies have consistently shown that Finerenone can slow the progression of kidney damage, reduce albuminuria, and protect against cardiovascular events in patients with type 2 diabetes. This makes it an indispensable compound for managing this complex comorbidity.

The finerenone benefits heart failure are also substantial. It helps to reduce cardiac fibrosis and inflammation, improving heart function and decreasing the likelihood of hospitalizations. The continuous updates from finerenone clinical trials provide strong evidence for its widespread adoption in clinical practice.

The finerenone chemical properties are well-defined, supporting its use as a high-quality API. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing Finerenone that meets the highest standards of purity and quality, essential for pharmaceutical manufacturing and advanced research.

For companies looking to source Finerenone, whether to purchase Finerenone or to order Finerenone for development, NINGBO INNO PHARMCHEM CO.,LTD. offers a reliable and high-quality supply chain. We are dedicated to supporting the pharmaceutical industry's progress in improving patient outcomes.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Finerenone in Focus: Tackling Cardiorenal Disease with Precision

Next: Finerenone: A Deep Dive into its Selectivity and Efficacy

All Rights Reserved